Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;51(2):128-31.
doi: 10.4111/kju.2010.51.2.128. Epub 2010 Feb 18.

Endoscopic Subureteral Injection for the Treatment of Vesicoureteral Reflux in Children: Polydimethylsiloxane (Macroplastique(R)) versus Dextranomer/Hyaluronic Acid Copolymer (Deflux(R))

Young Dae Bae  1 , Min Gu Park, Mi Mi Oh, Du Geon Moon
Affiliations

Endoscopic Subureteral Injection for the Treatment of Vesicoureteral Reflux in Children: Polydimethylsiloxane (Macroplastique(R)) versus Dextranomer/Hyaluronic Acid Copolymer (Deflux(R))

Young Dae Bae et al. Korean J Urol. 2010 Feb.

Abstract

Purpose: The aim of this study was to compare cure rates and complications of polydimethylsiloxane (Macroplastique(R)) and dextranomer/hyaluronic acid copolymer (Deflux(R)) in the treatment of vesicoureteral reflux (VUR).

Materials and methods: From April 2001 to March 2008, 29 boys and 42 girls (total of 115 ureters) with a mean age of 6 years who had undergone endoscopic subureteral transurethral injection for VUR were enrolled. A single subureteral injection of Macroplastique was performed in 31 ureters in 23 children (group I; grade II: 4; grade III: 12; grade IV: 9; grade V: 6), and a single subureteral injection of Deflux was performed in 84 ureters in 48 children (group II; grade II: 24; grade III: 14; grade IV: 25; grade V: 21). Renal ultrasound was done 1 day after injection, and voiding cystourethrography (VCUG) was done at 3 months. Successful reflux correction was defined as absent or grade I reflux on follow-up VCUG.

Results: No significant difference in success rates was observed between group I and group II [80.6% (25/31) vs. 78.6% (66/84), respectively, p>0.05]. The following postoperative complications developed: ureteral obstruction in 2 ureters of group I and 3 ureters of group II, asymptomatic urinary tract infection in 3 patients of group I and 2 patients of group II, and bladder calcification by erosion or mucosal necrosis in 2 patients of group I.

Conclusions: Despite differences in material properties, both Macroplastique and Deflux were safe for the treatment of children with VUR. Because of the risk of bladder mucosal necrosis and substantial decreases in volume after implantation, long-term follow-up is required.

Keywords: Deflux; Vesicoureteral reflux.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

References

    1. Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Treatment of vesico-ureteric reflux: a new algorithm based on parental preference. BJU Int. 2003;92:285–288. - PubMed
    1. Schulman CC, Pamart D, Hall M, Janssen F, Avni FE. Vesicoureteral reflux in children: endoscopic treatment. Eur Urol. 1990;17:314–317. - PubMed
    1. Joyner BD, Atala A. Endoscopic substances for the treatment of vesicoureteral reflux. Urology. 1997;50:489–494. - PubMed
    1. Stenberg A, Läckgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol. 1995;154:800–803. - PubMed
    1. Ozyavuz R, Ozgur GK, Yuzuncu AK. Subureteric polydimethylsiloxane injection in the treatment of vesico-ureteric reflux. Int Urol Nephrol. 1998;30:123–126. - PubMed